vs

Side-by-side financial comparison of Cheer Holding, Inc. (CHR) and TREACE MEDICAL CONCEPTS, INC. (TMCI). Click either name above to swap in a different company.

Cheer Holding, Inc. is the larger business by last-quarter revenue ($71.0M vs $62.5M, roughly 1.1× TREACE MEDICAL CONCEPTS, INC.). Cheer Holding, Inc. runs the higher net margin — 10.9% vs -15.0%, a 25.9% gap on every dollar of revenue. On growth, Cheer Holding, Inc. posted the faster year-over-year revenue change (-0.1% vs -9.0%).

Cheer Holding, Inc. is a diversified holding company primarily operating in the Chinese market, with core business segments covering early childhood education services, mobile lifestyle platforms, digital content offerings, and integrated consumer solutions for households and enterprise partners across multiple demand scenarios.

Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions.

CHR vs TMCI — Head-to-Head

Bigger by revenue
CHR
CHR
1.1× larger
CHR
$71.0M
$62.5M
TMCI
Growing faster (revenue YoY)
CHR
CHR
+8.9% gap
CHR
-0.1%
-9.0%
TMCI
Higher net margin
CHR
CHR
25.9% more per $
CHR
10.9%
-15.0%
TMCI

Income Statement — Q2 FY2025 vs Q4 FY2025

Metric
CHR
CHR
TMCI
TMCI
Revenue
$71.0M
$62.5M
Net Profit
$7.8M
$-9.4M
Gross Margin
70.7%
80.6%
Operating Margin
11.7%
-9.5%
Net Margin
10.9%
-15.0%
Revenue YoY
-0.1%
-9.0%
Net Profit YoY
-37.5%
-1775.0%
EPS (diluted)
$0.67
$-0.14

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CHR
CHR
TMCI
TMCI
Q4 25
$62.5M
Q3 25
$50.2M
Q2 25
$71.0M
$47.4M
Q1 25
$52.6M
Q4 24
$68.7M
Q3 24
$45.1M
Q2 24
$71.1M
$44.5M
Q1 24
$51.1M
Net Profit
CHR
CHR
TMCI
TMCI
Q4 25
$-9.4M
Q3 25
$-16.3M
Q2 25
$7.8M
$-17.4M
Q1 25
$-15.9M
Q4 24
$-501.0K
Q3 24
$-15.4M
Q2 24
$12.4M
$-21.2M
Q1 24
$-18.7M
Gross Margin
CHR
CHR
TMCI
TMCI
Q4 25
80.6%
Q3 25
79.1%
Q2 25
70.7%
79.7%
Q1 25
79.7%
Q4 24
80.7%
Q3 24
80.1%
Q2 24
73.4%
80.2%
Q1 24
80.2%
Operating Margin
CHR
CHR
TMCI
TMCI
Q4 25
-9.5%
Q3 25
-31.2%
Q2 25
11.7%
-35.8%
Q1 25
-29.6%
Q4 24
-0.3%
Q3 24
-33.6%
Q2 24
16.4%
-48.1%
Q1 24
-37.1%
Net Margin
CHR
CHR
TMCI
TMCI
Q4 25
-15.0%
Q3 25
-32.4%
Q2 25
10.9%
-36.7%
Q1 25
-30.3%
Q4 24
-0.7%
Q3 24
-34.1%
Q2 24
17.5%
-47.7%
Q1 24
-36.5%
EPS (diluted)
CHR
CHR
TMCI
TMCI
Q4 25
$-0.14
Q3 25
$-0.26
Q2 25
$0.67
$-0.28
Q1 25
$-0.25
Q4 24
$-0.01
Q3 24
$-0.25
Q2 24
$1.23
$-0.34
Q1 24
$-0.30

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CHR
CHR
TMCI
TMCI
Cash + ST InvestmentsLiquidity on hand
$48.4M
Total DebtLower is stronger
$55.6M
Stockholders' EquityBook value
$322.1M
$87.3M
Total Assets
$362.7M
$190.6M
Debt / EquityLower = less leverage
0.64×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CHR
CHR
TMCI
TMCI
Q4 25
$48.4M
Q3 25
$57.4M
Q2 25
$69.3M
Q1 25
$76.1M
Q4 24
$75.7M
Q3 24
$82.8M
Q2 24
$186.1M
$95.0M
Q1 24
$110.0M
Total Debt
CHR
CHR
TMCI
TMCI
Q4 25
$55.6M
Q3 25
$53.5M
Q2 25
$53.5M
Q1 25
$53.4M
Q4 24
$53.3M
Q3 24
$53.2M
Q2 24
$53.2M
Q1 24
$53.1M
Stockholders' Equity
CHR
CHR
TMCI
TMCI
Q4 25
$87.3M
Q3 25
$89.2M
Q2 25
$322.1M
$97.6M
Q1 25
$105.3M
Q4 24
$112.9M
Q3 24
$104.9M
Q2 24
$286.1M
$112.1M
Q1 24
$126.4M
Total Assets
CHR
CHR
TMCI
TMCI
Q4 25
$190.6M
Q3 25
$196.6M
Q2 25
$362.7M
$206.4M
Q1 25
$205.8M
Q4 24
$217.1M
Q3 24
$212.9M
Q2 24
$333.2M
$226.1M
Q1 24
$242.7M
Debt / Equity
CHR
CHR
TMCI
TMCI
Q4 25
0.64×
Q3 25
0.60×
Q2 25
0.55×
Q1 25
0.51×
Q4 24
0.47×
Q3 24
0.51×
Q2 24
0.47×
Q1 24
0.42×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CHR
CHR
TMCI
TMCI
Operating Cash FlowLast quarter
$3.9M
$-8.0M
Free Cash FlowOCF − Capex
$-10.4M
FCF MarginFCF / Revenue
-16.7%
Capex IntensityCapex / Revenue
3.8%
Cash ConversionOCF / Net Profit
0.51×
TTM Free Cash FlowTrailing 4 quarters
$-29.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CHR
CHR
TMCI
TMCI
Q4 25
$-8.0M
Q3 25
$-9.1M
Q2 25
$3.9M
$-3.0M
Q1 25
$4.2M
Q4 24
$-4.2M
Q3 24
$-11.8M
Q2 24
$-6.7M
$-13.9M
Q1 24
$-7.2M
Free Cash Flow
CHR
CHR
TMCI
TMCI
Q4 25
$-10.4M
Q3 25
$-11.9M
Q2 25
$-7.8M
Q1 25
$655.0K
Q4 24
$-7.3M
Q3 24
$-14.7M
Q2 24
$-15.6M
Q1 24
$-11.1M
FCF Margin
CHR
CHR
TMCI
TMCI
Q4 25
-16.7%
Q3 25
-23.7%
Q2 25
-16.5%
Q1 25
1.2%
Q4 24
-10.6%
Q3 24
-32.6%
Q2 24
-35.2%
Q1 24
-21.8%
Capex Intensity
CHR
CHR
TMCI
TMCI
Q4 25
3.8%
Q3 25
5.6%
Q2 25
10.1%
Q1 25
6.7%
Q4 24
4.5%
Q3 24
6.4%
Q2 24
3.9%
Q1 24
7.7%
Cash Conversion
CHR
CHR
TMCI
TMCI
Q4 25
Q3 25
Q2 25
0.51×
Q1 25
Q4 24
Q3 24
Q2 24
-0.54×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons